Seventeen women who met the criteria for bulimia nervosa (DSM-Ill-R) were treated for 4 weeks in an open trial with ipsapirone, a partial 5-HT,\* agonist. Bulimic symptoms diminished in 66.6% of the patients after only 7 week of treatment, 93.3% showed a reduction of more than 50% of weekly binge ea
Open trial of fluvoxamine in the treatment of bulimia nervosa
✍ Scribed by Ayuso-Gutierrez, José L. ;Palazón, Mónica ;Ayuso-Mateos, Josó L.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1994
- Tongue
- English
- Weight
- 316 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0276-3478
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Currently, the most effective treatment for bulimia nervosa (BN) is manualbased cognitive behavioral therapy (CBT) (Wilson and Fairburn, 1988a). The problem is that, while it is a good treatment, it is not good enough. Many patients show only partial improvement, and some none at all. The challenge
The sense of loss of control that accompanies the binge-eating episodes in bulimia nervosa is pathognomonic for the disorder. This experiment, with bulimics and control subjects, examined the role of cognitive and of dietary factors in an increased appetite. Subjects were required to eat a breakfast